A new exercise method for people with osteoarthritis and obesity
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
This study is testing a new exercise method using a special feedback system to help people with obesity and knee osteoarthritis walk better and manage their pain.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 30 Years to 75 Years |
| Sex | All |
| Sponsor | University of Southern Mississippi Academic / other |
| Locations | 1 site (Hattiesburg, Mississippi) |
| Trial ID | NCT05997862 on ClinicalTrials.gov |
What this trial studies
This study evaluates a hip flexion feedback system (HFFS) designed to improve exercise for individuals suffering from obesity and knee osteoarthritis. Participants will engage in walking exercises on a treadmill while focusing on lifting their knees to reduce joint impact and enhance mobility. The goal is to provide a safer and more effective way for these individuals to exercise, potentially leading to better pain management and overall health. The study is structured in two phases to assess both the feasibility and effectiveness of this innovative approach.
Who should consider this trial
Good fit: Ideal candidates are adults aged 30 to 75 with a BMI between 30 and 50 who have symptomatic knee osteoarthritis and are currently sedentary.
Not a fit: Patients with conditions such as fibromyalgia, rheumatoid arthritis, or those who have had recent knee surgeries may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the ability of patients with osteoarthritis and obesity to engage in exercise, leading to reduced pain and enhanced quality of life.
How similar studies have performed: While similar approaches to exercise for osteoarthritis have been explored, this specific method using HFFS is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 30 to 75 years; * BMI ≥ 30.0 kg/m2 and ≤ 50.0 kg/m2; * Symptomatic knee OA (defined as a self- report of physician diagnosis of knee OA and current knee symptoms in at least one knee determined from a minimum score of 5 of 20 on the pain subscale of the WOMAC). * Sedentary (not meeting ACSM guidelines for physical activity) * Medical clearance for participation Exclusion Criteria: * Self- reported fibromyalgia, rheumatoid arthritis, or other systemic rheumatic disease. * Severe dementia or other memory loss condition * Active diagnosis of psychosis or current uncontrolled substance abuse disorder * Has been hospitalized for a stroke, heart attack, or heart failure, or had surgery for blocked arteries in the past 3 months * Had a total joint replacement knee surgery, other knee surgery, meniscus tear, or anterior cruciate ligament tear in the past 6 months * Is on a waiting list for total joint replacement * Had an intra-articular injection in past 3 months or scheduled during the study period; * Has severely impaired hearing or speech * Is pregnant * Has a serious or terminal illness as indicated by referral to hospice or palliative care * Resides in a nursing home * Has any other health problems that would prohibit safe participation in the study
Where this trial is running
Hattiesburg, Mississippi
- University Southern Mississippi — Hattiesburg, Mississippi, United States (Recruiting)
Study contacts
- Study coordinator: Nuno Oliveira, PhD
- Email: nuno.oliveira@usm.edu
- Phone: 601-266-5804
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.